Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
911
Market Cap
0.32M

Momentum Score

…

BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

BioLife Sciences Inc (BLFE) is quoted on the OTC Pink; public disclosures provide limited detail on its core operations and product portfolio. Long-term growth may depend on successful product development, regulatory progress, strategic partnerships and additional financing, and the company may benefit if execution and transparency improve, making it more accessible to investors.

Material risks include limited public information and regulatory transparency, low trading liquidity typical of OTC Pink listings, likely need for additional capital, and execution and regulatory risks common to small, early-stage life‑sciences companies.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-0.64
ROE
-
Net Debt
-0.00M
ROCE
36382.93%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Income before tax - - - -0.00M -0.05M
Net income - - - -0.00M -0.05M
Ebit - -0.42M -1.27M 0.00M -
Ebitda - - - 0.17M -0.04M
Depreciation and amortization 0.23M - - 0.17M -
Operating income - - - - -0.04M
Other operating expenses - - - - 0.04M
Interest expense - 0.00M 0.00M - 0.01M
Total operating expenses - - - - 0.04M
Total other income expense net - - - -0.00M -0.01M
Net income applicable to common shares - -0.46M -1.27M - -
Breakdown 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Type yearly yearly yearly yearly yearly
Date 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Total assets - - 0.00M 0.00M 0.01M
Total liab - - 0.00M 0.22M 0.20M
Total stockholder equity - - -0.00M -0.22M -0.18M
Other current liab 0.09M 0.08M 0.00M - 0.05M
Common stock 0.01M 0.01M - 0.35M 0.33M
Retained earnings -1.73M -1.27M -0.00M -4.89M -4.84M
Cash - - 0.00M 0.00M 0.01M
Total current liabilities 1.07M 0.84M 0.00M 0.16M 0.13M
Net debt - - -0.00M 0.14M 0.13M
Short term debt - - - 0.08M 0.07M
Short long term debt total - - - 0.14M 0.14M
Other stockholder equity -0.01M -0.04M - 4.33M 4.66M
Property plant equipment 0.12M 0.20M - - -
Total current assets 0.08M 0.07M 0.00M 0.00M 0.01M
Net tangible assets -0.88M -0.69M - - -
Accounts payable 0.58M 0.49M - 0.08M -
Accumulated other comprehensive income - - - - -0.33M
Breakdown 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Type yearly yearly yearly yearly yearly
Date 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Change to liabilities 0.21M 0.30M - - -
Total cashflows from investing activities - -0.00M - - -
Net borrowings 0.07M 0.88M - - -
Total cash from financing activities 0.07M 0.99M - 0.00M 0.03M
Change to operating activities -0.02M -0.04M - - -
Net income -0.46M -1.27M -0.00M -0.05M -0.34M
Change in cash -0.02M 0.03M -0.00M -0.01M 0.01M
Begin period cash flow - 0.40M 0.00M 0.01M -
End period cash flow - - 0.00M 0.00M 0.01M
Total cash from operating activities -0.11M -1.00M 0.00M -0.01M -0.02M
Change to inventory - 0.00M - - -
Other cashflows from financing activities - 0.88M - 0.00M 0.03M
Change to netincome 0.16M 0.00M - - -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital - - 0.00M 0.03M 0.02M
Other non cash items - - -0.00M -0.01M 0.30M
Free cash flow - - 0.00M -0.01M -0.02M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BLFE
BioLife Sciences Inc
-
-%
0.00 - - 0.00 - 0.13 9.15
ISRG
Intuitive Surgical Inc
-8.32
2.04%
398.92 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme
-2.84
1.45%
192.96 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
-1.82
1.88%
95.04 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
0.10
0.05%
212.78 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

BioLife Sciences Inc

BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.

2831 Saint Rose Parkway, Henderson, NV, United States, 89052

833-919-1037

Name Title Year Born
Mr. Justin De Four Founder, CEO & Chairman 1990
Mr. Colton De Gooyer Director of Operations NA
Ms. Nika Jaksic COO & Director 1980
Ms. Nika Jaksic COO & Director 1981
Mr. Justin De Four Founder, CEO & Chairman 1991

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…